These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2002604)

  • 1. [Contractility and energetics in cardiac hypertrophy].
    Ito T
    Nihon Rinsho; 1991 Jan; 49(1):211-6. PubMed ID: 2002604
    [No Abstract]   [Full Text] [Related]  

  • 2. Can an energy-deficient heart grow bigger and stronger?
    Roberts R; Marian AJ
    J Am Coll Cardiol; 2003 May; 41(10):1783-5. PubMed ID: 12767665
    [No Abstract]   [Full Text] [Related]  

  • 3. The energetic cost of contraction is higher in the myocardium of patients with hypertrophic cardiomyopathy.
    Ingwall JS
    Cardiovasc Res; 2014 Jul; 103(2):192-3. PubMed ID: 24935429
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.
    Mahon N; Mckenna WJ
    Eur Heart J; 2000 Jul; 21(13):1034-6. PubMed ID: 10843817
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myocardial energy metabolism in congestive and hypertrophic states of cardiomyopathy in hamsters with elastase-induced emphysema].
    Morimoto Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Dec; 20(12):1221-9. PubMed ID: 6926435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy: pressure gradient and obstruction].
    Hamada M; Suzuki M
    Nihon Rinsho; 1991 Jan; 49(1):10-5. PubMed ID: 2002586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy].
    Bundgaard H; Havndrup O; Høst U; Kelbaek H
    Ugeskr Laeger; 1998 Sep; 160(38):5478-83. PubMed ID: 9763919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of diltiazem on myocardial contractility and energetics].
    Ando H; Yonenaga K; Kuboyama I; Ueno Y; Nakano E
    Rinsho Kyobu Geka; 1984 Sep; 4(5):561-6. PubMed ID: 6522981
    [No Abstract]   [Full Text] [Related]  

  • 9. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Both hypertrophy and atrophy contribute to the apex beat].
    Sakamoto T
    J Cardiol; 1995 Apr; 25(4):217-20. PubMed ID: 7752056
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Energetics in cardiac contraction].
    Inoue M; Hori M; Tsujioka K
    Iyodenshi To Seitai Kogaku; 1985 Dec; 23(7):447-51. PubMed ID: 3835327
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy.
    Liu H; Lee SS
    Liver Int; 2008 May; 28(5):640-8. PubMed ID: 18346133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of diastolic compliance, contractility and diastolic constraint of the left ventricle in obstructive myocardiopathy: inadequate myocardial hypertrophy].
    Le Pailleur C; Lafont H; Vacheron A; Heulin A; Di Mattéo J
    Arch Mal Coeur Vaiss; 1974 Dec; 67(12):1375-87. PubMed ID: 4219568
    [No Abstract]   [Full Text] [Related]  

  • 15. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
    Horowitz JD; Chirkov YY
    Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the mechanisms of cardiac hypertrophy].
    Pan DS; Tian C; Chen LY
    Sheng Li Ke Xue Jin Zhan; 1999 Apr; 30(2):113-7. PubMed ID: 12532802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac energetics. Basic mechanisms and clinical implications.
    Basic Res Cardiol; 1987; 82 Suppl 2():1-425. PubMed ID: 3663012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular mechanisms in cardiac hypertrophy and cardiomyopathy].
    Yazaki Y
    Nihon Rinsho; 1991 Jan; 49(1):217-25. PubMed ID: 1848325
    [No Abstract]   [Full Text] [Related]  

  • 19. [Noninvasive studies of the systolic phase and left-ventricular myocardial contractility in primary hypertrophic cardiomyopathy].
    Dubiel JP; Bielecki A
    Kardiol Pol; 1984; 27(4):257-65. PubMed ID: 6541727
    [No Abstract]   [Full Text] [Related]  

  • 20. [The system of cyclic nucleotides during myocardial hyperfunction and hypertrophy in rats of various ages].
    Kul'chitskiĭ OK; Efimov DA
    Vopr Med Khim; 1990; 36(5):69-71. PubMed ID: 2174589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.